Leonard Schleifer, Regeneron CEO (AP Images)
What happens when the N-of-1 is the president of the US? Regeneron is about to find out
President Trump is taking a very personal interest in another experimental drug for Covid-19.
Friday afternoon, after he had tested positive for coronavirus, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
